Apple Analyst Sees iPhone Sales Tanking 20% On Black Friday Weekend As Production Hit — Woes Could Last Through Christmas
Apple Inc.’s (NASDAQ: AAPL) newest iPhone iteration will be in short supply for the Black Friday holida
What’s Driving Tesla Shares Higher On Wednesday
Tesla Inc. (NASDAQ: TSLA) shares were advancing for a second straight session in premarket trading on Wednesday.
Salesforce Analyst Slashes Price Target By 14% To Reflect Broad-Based Macro Concerns In Front-Office Software
Wells Fargo analyst Michael Turrin maintained Salesforce Inc (NYSE:CRM) with an Overweight and reduced the price target from $220 to $190. Macro…
Yatra Online’s Indian Subsidiary IPO To Push US Shares Higher, Says Analyst
H.C. Wainwright analyst Scott Buck reiterated a Buy rating on the shares of Yatra Online Inc (NASDAQ:YTRA) with a price target of…
Synopsys Analyst Slashes Price Target By 6% To Be In Line With Peers
Wells Fargo analyst Gary Mobley maintains Synopsys Inc (NASDAQ:SNPS) with an Overweight and lowered the price target from $425 to $400. Ahead…
Marvell Technology Is Heavily Insulated From Consumer Weakness, Can Outperform Peers In Broader Chip Sector
Wells Fargo analyst Gary Mobley reiterated Marvell Technology, Inc (NASDAQ:MRVL) with an Overweight with a $58 price target. While MRVL will not…
Ross Stores’ Low Q4 Bar, Improving Inventory, Potential Trade Down Triggers 7% Price Target Hike By Morgan Stanley
Morgan Stanley analyst Alex Straton reiterated an Overweight rating on the shares of Ross Stores Inc (NASDAQ:ROST) and raised the price target…
Analyst Says IO Biotech’s Cancer Treatment Approach ‘Differentiated’
HC Wainwright has initiated coverage on Denmark-based cancer firm IO Biotech Inc (NASDAQ:IOBT) with a Buy rating and a price target of $10.…
This Analyst Is Bullish On Evolent Health’s Recent Deal, Calls ‘Highly Strategic Acquisition’
Thursday after close, Evolent Health Inc (NYSE:EVH) agreed to acquire Magellan Specialty Health, the specialty benefit management organization owned by Centene…
Alibaba Will Be Critical Beneficiary Of China’s Reopening and Economic Recovery, Analysts Say
Mizuho analyst James Lee maintained Alibaba Group Holding Ltd (NYSE:BABA) with a Buy and cut the price target from $160 to $155.…